Eukaryotic translation elongation factor 1 alpha 1 pseudogene 23 (EEF1A1P23)

EEF1A1P23 is classified as a *pseudogene* of the **Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1)** gene, which encodes a key factor involved in protein synthesis by delivering aminoacyl-tRNAs to the ribosome during translation elongation[1][3][2]. Pseudogenes like EEF1A1P23 do not encode functional proteins and generally arise from retrotransposition or gene duplication events followed by mutational inactivation[2]. While some pseudogenes exert regulatory influences (e.g., as non-coding RNAs regulating their parental gene), there is no evidence that EEF1A1P23 has such a function, nor is it implicated as a biomarker, drug target, or driver in human disease[2][1].\n\nThe parental gene, EEF1A1, is essential in translation and has multiple pseudogenes spread throughout the genome; some of these have been studied, but EEF1A1P23 specifically is not characterized for any functional, disease, or therapeutic relevance[2][1]. It is not classified as a receptor, enzyme, transporter, or transcription factor, and thus does not fit into typical anatomical/functional target classes. "Pseudogene" by definition means it is not a functional gene and, unless noted otherwise, does not produce a protein or have known direct phenotypic effects.\n\nAccording to current knowledge and major databases, **EEF1A1P23** is not a valid drug target and should not be classified as such for structured biological or pharmacological data curation[1][3][6].

Other names

EEF1A1P23